Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freeze-thawing: insights into the roles of particles in the protein aggregation pathway.

The objective of this study was to evaluate microflow imaging (MFI) as a sensitive tool to detect and quantify subvisible particle formation during freeze-thawing of an IgG(2) monoclonal antibody (mAb). Solutions of the protein formulated in 20 mM of histidine buffer (pH 5.5) were subjected to three freeze-thaw cycles and analyzed by MFI and size-exclusion chromatography (SEC). MFI showed increased particle numbers after each freeze-thaw cycle, whereas aggregates were not detected by SEC. Estimates of the total mass of particles formed revealed that monitoring of particle formation allows for the detection of protein aggregates comprising only hundredths of a percent of the total protein mass. Furthermore, differences in protein aggregation levels due to different formulations or different freeze-thawing protocols were resolved, even though protein aggregation could not be detected by SEC. To examine whether SEC and MFI-based estimations of total aggregate mass were in quantitative agreement, mAb was freeze-thawed in phosphate-buffered saline. This process created sufficient level of insoluble aggregates to be detected by SEC as a reduction in the monomer peak area in the chromatogram. There was good agreement between the loss of monomer detected by SEC and the total mass of subvisible particles detected by MFI.

[1]  John P. Gabrielson,et al.  Detection of protein aggregates by sedimentation velocity analytical ultracentrifugation (SV-AUC): sources of variability and their relative importance. , 2009, Journal of pharmaceutical sciences.

[2]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Manning,et al.  Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII. , 1998, Journal of pharmaceutical sciences.

[4]  B. Matthews,et al.  Accurate calculation of the density of proteins. , 2000, Acta crystallographica. Section D, Biological crystallography.

[5]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[6]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[7]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[8]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[9]  I. Apostol,et al.  Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications. , 1999, Journal of pharmaceutical sciences.

[10]  M. Manning,et al.  Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. , 2005, Journal of pharmaceutical sciences.

[11]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[12]  M. Manning,et al.  Infrared and circular dichroism spectroscopic characterization of structural differences between beta-lactoglobulin A and B. , 1996, Biochemistry.

[13]  Theodore W Randolph,et al.  IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. , 2009, Journal of pharmaceutical sciences.

[14]  Bruce A Kerwin,et al.  Protect from light: photodegradation and protein biologics. , 2007, Journal of pharmaceutical sciences.

[15]  Hanns-Christian Mahler,et al.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  W. Jiskoot,et al.  Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Hanns-Christian Mahler,et al.  Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation. , 2010, Journal of pharmaceutical sciences.

[18]  B. Kerwin,et al.  Effects of Tween 80 and Sucrose on Acute Short-Term Stability and Long-Term Storage at − 20 C of a Recombinant Hemoglobin , 1998 .

[19]  Hanns-Christian Mahler,et al.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody. , 2008, Journal of pharmaceutical sciences.